Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nociceptive transmission-associated neurotransmitters refer to a group of chemical messengers, primarily excitatory neuropeptides and amino acids, that facilitate the transmission of pain signals from peripheral nociceptors to the central nervous system. Key members include glutamate, the primary excitatory neurotransmitter, and neuropeptides such as Substance P, Calcitonin Gene-Related Peptide (CGRP), and Cholecystokinin (CCK). These molecules are released from the central terminals of primary afferent fibers, such as A-delta and C fibers, into the dorsal horn of the spinal cord or the trigeminal nucleus caudalis. In chronic pain conditions or migraine, the pathological upregulation of these neurotransmitters leads to increased neuronal excitability and central sensitization. Therapeutic interventions targeting this category involve inhibiting their release (e.g., via opioids or triptans) or antagonizing their respective receptors (e.g., CGRP or NK1 receptors) to alleviate pain and restore normal sensory processing.
Inhibition of neurotransmitter release from presynaptic terminals (e.g., via 5-HT1B/1D or opioid receptor activation) and antagonism of postsynaptic receptors (e.g., NK1, CGRP, or NMDA receptors) to block the propagation of noxious stimuli.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nociceptive transmission-associated neurotransmitter.